An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen

Medicpen AB25 enrolled

Overview

This is a study of the electronical dosing tool MedicPen and it's qualities with regards to user friendliness and medication compliance.

The medical device MedicPen will be investigated for it's qualities with regards to medication compliance and user friendliness. The patient group selected here is patients with Crohn's disease that are treated with Azathioprine. The patient selection was made since the metabolite can be easily measured and the compliance can be therefore be followed. The treatment will follow the standard care given to these patients.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Crohn's Disease Ulcerative Colitis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female * 18 years or older * Provided written informed consent * Diagnosed with Chron's disease or Ulcerative Colitis * Treated with Azathiprine for at least 6 months prior to study start Exclusion Criteria: * Patients who are, for some reason, judged by the responsible investigator to be unable to handle the device to be tested.

Locations (1)

Department for Gastrointestinal medicin Karolinska University Hospital

Huddinge, Sweden

Outcomes

Primary Outcomes

User friendliness of Dosing Tool MedicPen

Time frame: June 2009 to Nov 2009

Secondary Outcomes

Measure treatment compliance

Time frame: June 2009 to Nov 2009

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.